Mitochondrial peptide MOTS-c suppresses systemic and cardiac inflammasome activation in a diabetic rat model.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: Exact-ID Europe PMC status checked Sep 25, 2026. No retraction or correction publication-type marker was listed in that response. This does not rule out other updates.

Study metadata

Study type: Original study
Study category (metadata hint): Animal
Published: 2026-06-19
Authors: Mills AR, de Souza A, Pham T, Mugisho OO.
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: Health Research Council of New Zealand; Heart Foundation of New Zealand Research Fellowship; Auckland Medical Research Foundation; Emerging Research First Grants
Identifiers: DOI: 10.1113/ep093714 · PMID: 42321010 · PMCID: PMC13394035
First found: Sep 24, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗View at PubMed ↗